The estimated Net Worth of Pra Investors L.P.Kkr Pra I... is at least 654 百万$ dollars as of 6 September 2019. Pra I owns over 6,666,684 units of PRA Health Sciences Inc stock worth over 4,840,653$ and over the last 5 years Pra sold PRAH stock worth over 649,401,688$.
Sign up
Pra I PRAH stock SEC Form 4 insiders trading
Pra has made over 1 trades of the PRA Health Sciences Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently Pra sold 6,666,684 units of PRAH stock worth 649,401,688$ on 6 September 2019.
The largest trade Pra's ever made was selling 6,666,684 units of PRA Health Sciences Inc stock on 6 September 2019 worth over 649,401,688$. On average, Pra trades about 6,666,684 units every 0 days since 2019. As of 6 September 2019 Pra still owns at least 29,300 units of PRA Health Sciences Inc stock.
You can see the complete history of Pra I stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Insiders trading at PRA Health Sciences Inc
Over the last 10 years, insiders at PRA Health Sciences Inc have traded over 5,843,308,181$ worth of PRA Health Sciences Inc stock. The most active insiders traders include Fund Holdings L.P.Kkr Fund ...、Fund Holdings L.P.Kkr Fund ...、Pra Investors L.P.Kkr Pra I.... On average, PRA Health Sciences Inc executives and independent directors trade stock every 39 days with the average trade being worth of 280,602,577$. The most recent stock trade was executed by Christopher L Gaenzle on 17 June 2021, trading 27,497 units of PRAH stock currently worth 2,773,897$.
What does PRA Health Sciences Inc do?
PRA is one of the world's leading global contract research organizations by revenue, providing outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries. PRA's global clinical development platform includes more than 70 offices across North America, Europe, Asia, Latin America, South Africa, Australia and the Middle East and more than 18,100 employees worldwide. Since 2000, PRA has participated in approximately 4,200 clinical trials worldwide. In addition, PRA has participated in the pivotal or supportive trials that led to U.S. Food and Drug Administration or international regulatory approval of more than 100 drugs.
What does PRA Health Sciences Inc's logo look like?
Complete history of Pra I stock trades at PRA Health Sciences Inc
PRA Health Sciences Inc executives and stock owners
PRA Health Sciences Inc executives and other stock owners filed with the SEC include:
-
Colin Shannon,
Chairman of the Board, President, Chief Executive Officer -
Michael Bonello,
Chief Financial Officer, Executive Vice President -
Colin Shannon,
Chairman, CEO & Pres -
Linda Grais,
Independent Director -
Jeffrey Barber,
Independent Director -
Matthew Young,
Independent Director -
Alexander Dickinson,
Independent Director -
James Momtazee,
Lead Independent Director -
Glen Stettin,
Independent Director -
Christopher Gaenzle,
Executive Vice President, Chief Administrative Officer, General Counsel -
Dr. Michael Kirchengast,
Sr. VP of Scientific Affairs -
Patrick R. Spine,
VP of HR -
Tami Klerr-Naivar,
Exec. VP and Chief Sales & Marketing Officer -
Laurie Hurst,
Sr. Director of Communications & PR -
Thomas Byrne,
VP of Legal Affairs -
Kent Thoelke,
Exec. VP & Chief Scientific Officer -
Margaret Keegan,
Exec. VP & COO -
Pra Investors L.P.Kkr Pra I...,
-
Fund Holdings L.P.Kkr Fund ...,
-
Fund Holdings L.P.Kkr Fund ...,
-
David W Dockhorn,
Executive VP & CCO -
Linda Baddour,
Executive VP & CFO -
Pra Investors L.P.Kkr Pra I...,
-
Group Ltd Kkr Group Holding...,
-
Fund Holdings L.P.Kkr Fund ...,